Biden Reason 4 O O
admin Reason 4 O O
probes Reason 4 O O
risk Reason 4 O O
of Reason 4 O O
low-level Reason 4 O O
contamination Reason 4 O O
in Reason 4 O O
vaccines Reason 4 O O
made Reason 4 O O
at Reason 4 O O
troubled Reason 4 O O
plant Reason 4 O O
The Reason 4 ScientificAuthority O
Food Reason 4 ScientificAuthority O
and Reason 4 ScientificAuthority O
Drug Reason 4 ScientificAuthority O
Administration Reason 4 ScientificAuthority O
is Reason 4 O O
working Reason 4 O O
with Reason 4 O O
shot Reason 4 O O
makers Reason 4 O O
to Reason 4 O O
ensure Reason 4 O O
doses Reason 4 O O
manufactured Reason 4 O O
by Reason 4 O O
contractor Reason 4 O O
Emergent Reason 4 O O
BioSolutions Reason 4 O O
are Reason 4 O O
safe Reason 4 O O
to Reason 4 O O
use. Reason 4 O O
The O O O O
Food O O ScientificAuthority O
and O O ScientificAuthority O
Drug O O ScientificAuthority O
Administration O O ScientificAuthority O
has O O O O
asked O O O O
Johnson O O O O
& O O O O
Johnson O O O O
and O O O O
AstraZeneca O O O O
to O O O O
assess O O O O
any O O O O
potential O O O O
health O O O O
risks O O O O
from O O O O
minor O O O O
cross-contamination O O O O
of O O O O
their O O O O
Covid-19 O O O O
vaccines, O O O O
two O O O O
people O O O O
familiar O O O O
with O O O O
those O O O O
conversations O O O O
told O O O O
POLITICO. O O O O
The O O O O
agency O O O O
requested O O O O
the O O O O
analyses O O O O
because O O O O
it O O O O
cannot O O O O
rule O O O O
out O O O O
low-level O O O O
contamination O O O O
of O O O O
doses O O O O
of O O O O
both O O O O
vaccines O O O O
manufactured O O O O
by O O O O
contractor O O O O
Emergent O O O O
BioSolutions. O O O O
In Reason 2 O O
March, Reason 2 O O
Emergent's Reason 2 O O
Baltimore Reason 2 O O
facility Reason 2 O O
accidentally Reason 2 O O
contaminated Reason 2 O O
15 Reason 2 O O
million Reason 2 O O
Johnson Reason 2 O O
& Reason 2 O O
Johnson Reason 2 O O
doses Reason 2 O O
with Reason 2 O O
the Reason 2 O O
active Reason 2 O O
ingredient Reason 2 O O
of Reason 2 O O
AstraZeneca's Reason 2 O O
vaccine. Reason 2 O O
Production O O O O
at O O O O
the O O O O
plant O O O O
stopped O O O O
in O O O O
April O O O O
and O O O O
the O O O O
FDA O O ScientificAuthority O
began O O O O
investigating O O O O
the O O O O
matter. O O O O
The Reason 2 O O
agency Reason 2 O O
has Reason 2 O O
been Reason 2 O O
trying Reason 2 O O
to Reason 2 O O
determine Reason 2 O O
whether Reason 2 O O
Emergent Reason 2 O O
also Reason 2 O O
contaminated Reason 2 O O
any Reason 2 O O
of Reason 2 O O
the Reason 2 O O
other Reason 2 O O
millions Reason 2 O O
of Reason 2 O O
doses Reason 2 O O
of Reason 2 O O
the Reason 2 O O
J&J Reason 2 O O
and Reason 2 O O
AstraZeneca Reason 2 O O
vaccines Reason 2 O O
it Reason 2 O O
made. Reason 2 O O
While O O O O
available O O O O
testing O O O O
methods O O O O
can O O O O
identify O O O O
major O O O O
contamination O O O O
problems, O O O O
they O O O O
are O O O O
not O O O O
always O O O O
capable O O O O
of O O O O
tracing O O O O
small O O O O
amounts O O O O
of O O O O
contamination. O O O O
To O O O O
clear O O O O
the O O O O
doses O O O O
manufactured O O O O
at O O O O
Emergent O O O O
as O O O O
safe, O O O O
the O O O O
FDA O O ScientificAuthority O
has O O O O
asked O O O O
AstraZeneca O O O O
and O O O O
J&J O O O O
to O O O O
assess O O O O
any O O O O
risks O O O O
from O O O O
possible O O O O
trace O O O O
contamination O O O O
— O O O O
a O O O O
process O O O O
that O O O O
has O O O O
taken O O O O
several O O O O
weeks. O O O O
The O O O O
agency O O O O
is O O O O
expected O O O O
to O O O O
make O O O O
an O O O O
announcement O O O O
in O O O O
the O O O O
coming O O O O
days O O O O
about O O O O
whether O O O O
the O O O O
shots O O O O
made O O O O
by O O O O
Emergent O O O O
are O O O O
fit O O O O
for O O O O
use. O O O O
Some Reason 2 O O
of Reason 2 O O
the Reason 2 O O
doses Reason 2 O O
included Reason 2 O O
in Reason 2 O O
the Reason 2 O O
risk Reason 2 O O
assessment Reason 2 O O
include Reason 2 O O
AstraZeneca Reason 2 O O
shots Reason 2 O O
the Reason 2 O O
U.S. Reason 2 O O
government Reason 2 O O
has Reason 2 O O
already Reason 2 O O
shipped Reason 2 O O
to Reason 2 O O
Mexico Reason 2 O O
and Reason 2 O O
Canada, Reason 2 O O
the Reason 2 O O
two Reason 2 O O
individuals Reason 2 O O
familiar Reason 2 O O
with Reason 2 O O
the Reason 2 O O
matter Reason 2 O O
said. Reason 2 O O
The O O O O
U.S. O O O O
sent O O O O
those O O O O
doses O O O O
abroad O O O O
in O O O O
March O O O O
before O O O O
the O O O O
Biden O O O O
administration O O O O
became O O O O
aware O O O O
of O O O O
the O O O O
contamination O O O O
at O O O O
the O O O O
Emergent O O O O
plant O O O O
in O O O O
Baltimore. O O O O
Canadian O O O O
and O O O O
Mexican O O O O
officials O O O O
said O O O O
at O O O O
the O O O O
time O O O O
that O O O O
AstraZeneca O O O O
assured O O O O
them O O O O
that O O O O
the O O O O
doses O O O O
were O O O O
safe O O O O
for O O O O
use. O O O O
The O O O O
FDA O O ScientificAuthority O
declined O O O O
to O O O O
comment. O O O O
AstraZeneca O O O O
did O O O O
not O O O O
respond O O O O
to O O O O
requests O O O O
for O O O O
comment. O O O O
"The Reason 5 O O
quality Reason 5 O O
and Reason 5 O O
safety Reason 5 O O
of Reason 5 O O
our Reason 5 O O
COVID-19 Reason 5 O O
vaccine Reason 5 O O
are Reason 5 O O
paramount," Reason 5 O O
J&J Reason 5 O O
spokesperson Reason 5 O O
Jake Reason 5 O O
Sargent Reason 5 O O
said. Reason 5 O O
"We O O O O
continue O O O O
to O O O O
work O O O O
with O O O O
FDA O O ScientificAuthority O
and O O O O
Emergent O O O O
toward O O O O
adding O O O O
Emergent's O O O O
[Baltimore] O O O O
facility O O O O
to O O O O
Johnson O O O O
& O O O O
Johnson's O O O O
existing O O O O
Emergency O O O O
Use O O O O
Authorization O O O O
as O O O O
soon O O O O
as O O O O
possible." O O O O
It Reason 3 O O
is Reason 3 O O
possible Reason 3 O O
that Reason 3 O O
AstraZeneca Reason 3 O O
and Reason 3 O O
Johnson Reason 3 O O
& Reason 3 O O
Johnson Reason 3 O O
could Reason 3 O O
find Reason 3 O O
minor Reason 3 O O
contamination Reason 3 O O
in Reason 3 O O
the Reason 3 O O
vaccine Reason 3 O O
made Reason 3 O O
by Reason 3 O O
Emergent, Reason 3 O O
but Reason 3 O O
that Reason 3 O O
would Reason 3 O O
not Reason 3 O O
necessarily Reason 3 O O
make Reason 3 O O
those Reason 3 O O
doses Reason 3 O O
less Reason 3 O O
safe Reason 3 O O
overall, Reason 3 O O
the Reason 3 O O
two Reason 3 O O
individuals Reason 3 O O
involved Reason 3 O O
in Reason 3 O O
the Reason 3 O O
risk Reason 3 O O
assessment Reason 3 O O
discussions Reason 3 O O
said. Reason 3 O O
FDA Reason 4 ScientificAuthority O
clearance Reason 4 O O
of Reason 4 O O
the Reason 4 O O
J&J Reason 4 O O
and Reason 4 O O
AstraZeneca Reason 4 O O
doses Reason 4 O O
would Reason 4 O O
mark Reason 4 O O
a Reason 4 O O
major Reason 4 O O
development Reason 4 O O
in Reason 4 O O
the Reason 4 O O
Biden Reason 4 O O
administration's Reason 4 O O
efforts Reason 4 O O
to Reason 4 O O
help Reason 4 O O
vaccinate Reason 4 O O
the Reason 4 O O
rest Reason 4 O O
of Reason 4 O O
the Reason 4 O O
world. Reason 4 O O
The O O O O
Biden O O O O
administration O O O O
pledged O O O O
to O O O O
send O O O O
60 O O O O
million O O O O
doses O O O O
of O O O O
AstraZeneca's O O O O
vaccine, O O O O
which O O O O
is O O O O
not O O O O
authorized O O O O
in O O O O
the O O O O
U.S., O O O O
to O O O O
countries O O O O
in O O O O
need. O O O O
The O O O O
federal O O O O
government O O O O
has O O O O
been O O O O
unable O O O O
to O O O O
fulfill O O O O
its O O O O
promises O O O O
in O O O O
part O O O O
because O O O O
it O O O O
is O O O O
waiting O O O O
for O O O O
the O O O O
FDA O O ScientificAuthority O
to O O O O
clear O O O O
the O O O O
doses O O O O
for O O O O
use. O O O O
The Reason 4 O O
White Reason 4 O O
House, Reason 4 O O
in Reason 4 O O
coordination Reason 4 O O
with Reason 4 O O
the Reason 4 O O
State Reason 4 O O
Department Reason 4 O O
and Reason 4 O O
the Reason 4 O O
National Reason 4 O O
Security Reason 4 O O
Council, Reason 4 O O
is Reason 4 O O
set Reason 4 O O
to Reason 4 O O
announce Reason 4 O O
which Reason 4 O O
countries Reason 4 O O
will Reason 4 O O
receive Reason 4 O O
the Reason 4 O O
vaccine Reason 4 O O
doses Reason 4 O O
in Reason 4 O O
the Reason 4 O O
coming Reason 4 O O
days, Reason 4 O O
three Reason 4 O O
senior Reason 4 O O
U.S. Reason 4 O O
officials Reason 4 O O
told Reason 4 O O
POLITICO. Reason 4 O O
A Reason 4 O O
team Reason 4 O O
of Reason 4 O O
administration Reason 4 O O
officials Reason 4 O O
has Reason 4 O O
for Reason 4 O O
weeks Reason 4 O O
combed Reason 4 O O
through Reason 4 O O
more Reason 4 O O
than Reason 4 O O
four Reason 4 O O
dozen Reason 4 O O
requests Reason 4 O O
from Reason 4 O O
countries Reason 4 O O
around Reason 4 O O
the Reason 4 O O
world, Reason 4 O O
creating Reason 4 O O
a Reason 4 O O
rubric Reason 4 O O
to Reason 4 O O
identify Reason 4 O O
which Reason 4 O O
nations Reason 4 O O
should Reason 4 O O
receive Reason 4 O O
the Reason 4 O O
doses Reason 4 O O
first. Reason 4 O O
AstraZeneca O O O O
was O O O O
forced O O O O
to O O O O
find O O O O
a O O O O
new O O O O
contract O O O O
manufacturer O O O O
to O O O O
help O O O O
produce O O O O
its O O O O
vaccine O O O O
after O O O O
the O O O O
problems O O O O
at O O O O
the O O O O
Emergent O O O O
plant O O O O
were O O O O
revealed. O O O O
The O O O O
New O O O O
York O O O O
Times O O O O
[reported O O O O
Wednesday](https://www.nytimes.com/live/2021/06/02/world/covid-vaccine-coronavirus-mask#astrazeneca-covid-vaccine) O O O O
that O O O O
the O O O O
company O O O O
has O O O O
signed O O O O
a O O O O
deal O O O O
with O O O O
the O O O O
contract O O O O
manufacturer O O O O
Catalent. O O O O
The Reason 4 O O
J&J Reason 4 O O
vaccine Reason 4 O O
is Reason 4 O O
authorized Reason 4 O O
for Reason 4 O O
use Reason 4 O O
in Reason 4 O O
the Reason 4 O O
United Reason 4 O O
States. Reason 4 O O
If Reason 4 O O
the Reason 4 O O
FDA Reason 4 ScientificAuthority O
declares Reason 4 O O
that Reason 4 O O
existing Reason 4 O O
doses Reason 4 O O
made Reason 4 O O
by Reason 4 O O
Emergent Reason 4 O O
are Reason 4 O O
safe, Reason 4 O O
the Reason 4 O O
company Reason 4 O O
would Reason 4 O O
be Reason 4 O O
free Reason 4 O O
to Reason 4 O O
distribute Reason 4 O O
them. Reason 4 O O
Emergent's Reason 3 O O
CEO, Reason 3 O O
Robert Reason 3 O O
Kramer, Reason 3 O O
told Reason 3 O O
a Reason 3 O O
House Reason 3 O O
committee Reason 3 O O
last Reason 3 O O
month Reason 3 O O
that Reason 3 O O
there Reason 3 O O
"are Reason 3 O O
probably Reason 3 O O
over Reason 3 O O
100 Reason 3 O O
million Reason 3 O O
doses Reason 3 O O
of Reason 3 O O
the Reason 3 O O
J&J Reason 3 O O
vaccine Reason 3 O O
that Reason 3 O O
we've Reason 3 O O
manufactured Reason 3 O O
that Reason 3 O O
are Reason 3 O O
now Reason 3 O O
being Reason 3 O O
evaluated Reason 3 O O
by Reason 3 O O
the Reason 3 O O
FDA Reason 3 ScientificAuthority O
for Reason 3 O O
potential Reason 3 O O
release Reason 3 O O
and Reason 3 O O
availability." Reason 3 O O
"As Reason 3 O O
far Reason 3 O O
as Reason 3 O O
I Reason 3 O O
understand, Reason 3 O O
there Reason 3 O O
had Reason 3 O O
been Reason 3 O O
a Reason 3 O O
request Reason 3 O O
for Reason 3 O O
some Reason 3 O O
additional Reason 3 O O
testing Reason 3 O O
on Reason 3 O O
all Reason 3 O O
of Reason 3 O O
those Reason 3 O O
lots Reason 3 O O
and Reason 3 O O
doses Reason 3 O O
that Reason 3 O O
had Reason 3 O O
been Reason 3 O O
provided Reason 3 O O
by Reason 3 O O
J&J Reason 3 O O
to Reason 3 O O
the Reason 3 O O
FDA," Reason 3 ScientificAuthority O
Kramer Reason 3 O O
said. Reason 3 O O
A Reason 3 O O
person Reason 3 O O
with Reason 3 O O
direct Reason 3 O O
knowledge Reason 3 O O
of Reason 3 O O
the Reason 3 O O
situation Reason 3 O O
said Reason 3 O O
FDA Reason 3 ScientificAuthority O
regulators Reason 3 O O
were Reason 3 O O
set Reason 3 O O
to Reason 3 O O
visit Reason 3 O O
the Reason 3 O O
Emergent Reason 3 O O
Baltimore Reason 3 O O
facility Reason 3 O O
Wednesday Reason 3 O O
— Reason 3 O O
a Reason 3 O O
final Reason 3 O O
step Reason 3 O O
in Reason 3 O O
its Reason 3 O O
review Reason 3 O O
of Reason 3 O O
the Reason 3 O O
plant's Reason 3 O O
operations Reason 3 O O
after Reason 3 O O
it Reason 3 O O
determined Reason 3 O O
in Reason 3 O O
April Reason 3 O O
that Reason 3 O O
the Reason 3 O O
facility Reason 3 O O
had Reason 3 O O
significant Reason 3 O O
cleanliness Reason 3 O O
and Reason 3 O O
quality Reason 3 O O
control Reason 3 O O
issues. Reason 3 O O
Following O O O O
the O O O O
FDA's O O ScientificAuthority O
citation, O O O O
J&J O O O O
stepped O O O O
in O O O O
to O O O O
help O O O O
run O O O O
the O O O O
Emergent O O O O
facility O O O O
and O O O O
implement O O O O
stricter O O O O
oversight O O O O
policies. O O O O
But Reason 3 O O
production Reason 3 O O
cannot Reason 3 O O
resume Reason 3 O O
until Reason 3 O O
the Reason 3 O O
agency Reason 3 O O
is Reason 3 O O
satisfied Reason 3 O O
that Reason 3 O O
Emergent Reason 3 O O
and Reason 3 O O
J&J Reason 3 O O
have Reason 3 O O
addressed Reason 3 O O
the Reason 3 O O
problems Reason 3 O O
at Reason 3 O O
the Reason 3 O O
plant. Reason 3 O O
